Treatment of dyskinesia
US7935718B2 · kind B2 · utility
0Cited by
10References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 28, 2004 |
| Grant date | May 3, 2011 |
| Priority date | — |
| Expiry date | Apr 24, 2027 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the use of compounds that enhance H3-histamine receptor activity, or activation (e.g. H3-histamine receptor agonists) for the treatment of dyskinesia. The compounds are particularly useful for treating dyskinesia associated with parkinsonian therapy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.